Cargando…

RNA‐Peptide nanoplexes drug DNA damage pathways in high‐grade serous ovarian tumors

DNA damaging chemotherapy is a cornerstone of current front‐line treatments for advanced ovarian cancer (OC). Despite the fact that a majority of these patients initially respond to therapy, most will relapse with chemo‐resistant disease; therefore, adjuvant treatments that synergize with DNA‐damagi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dreaden, Erik C., Kong, Yi Wen, Quadir, Mohiuddin A., Correa, Santiago, Suárez‐López, Lucia, Barberio, Antonio E., Hwang, Mun Kyung, Shi, Aria C., Oberlton, Benjamin, Gallagher, Paige N., Shopsowitz, Kevin E., Elias, Kevin M., Yaffe, Michael B., Hammond, Paula T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773954/ https://www.ncbi.nlm.nih.gov/pubmed/29376131 http://dx.doi.org/10.1002/btm2.10086

Ejemplares similares

Periodic-shRNA molecules are capable of gene silencing, cytotoxicity and innate immune activation in cancer cells
por: Shopsowitz, Kevin E., et al.
Publicado: (2016)

Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints
por: Kong, Yi Wen, et al.
Publicado: (2020)

PEG–Polypeptide Block Copolymers as pH-Responsive Endosome-Solubilizing Drug Nanocarriers
por: Quadir, Mohiuddin A., et al.
Publicado: (2014)

A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
por: Liao, Longyan, et al.
Publicado: (2014)

Bimodal Tumor-Targeting from Microenvironment Responsive Hyaluronan Layer-by-Layer (LbL) Nanoparticles
por: Dreaden, Erik C., et al.
Publicado: (2014)

A Multi‐RNAi Microsponge Platform for Simultaneous Controlled Delivery of Multiple Small Interfering RNAs
por: Roh, Young Hoon, et al.
Publicado: (2015)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C
por: Aznar, M. Angela, et al.
Publicado: (2019)

Layer-by-Layer Assembled Antisense DNA Microsponge Particles for Efficient Delivery of Cancer Therapeutics
por: Roh, Young Hoon, et al.
Publicado: (2014)

Antimicrobial Nanoplexes meet Model Bacterial Membranes: the key role of Cardiolipin
por: Marín-Menéndez, Alejandro, et al.
Publicado: (2017)

Surface-Modified HK:siRNA Nanoplexes with Enhanced Pharmacokinetics and Tumor Growth Inhibition
por: Chou, Szu-Ting, et al.
Publicado: (2013)

Regulating intracellular fate of siRNA by endoplasmic reticulum membrane-decorated hybrid nanoplexes
por: Qiu, Chong, et al.
Publicado: (2019)

A Nanoplex PCR Assay for the Simultaneous Detection of Vancomycin- and Linezolid-Resistant Genes in Enterococcus
por: Wada, Yusuf, et al.
Publicado: (2023)

Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
por: Cosco, Donato, et al.
Publicado: (2015)

Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells
por: Lin, Guimiao, et al.
Publicado: (2017)

A nanoplex PCR assay for the rapid detection of vancomycin and bifunctional aminoglycoside resistance genes in Enterococcus species
por: Yean, Chan Yean, et al.
Publicado: (2007)

Lyophilization of Curcumin–Albumin Nanoplex with Sucrose as Cryoprotectant: Aqueous Reconstitution, Dissolution, Kinetic Solubility, and Physicochemical Stability
por: Chua, Angeline, et al.
Publicado: (2022)

Encapsulating Polyethyleneimine-DNA Nanoplexes into PEGylated Biodegradable Microparticles Increases Transgene Expression In Vitro and Reduces Inflammatory Responses In Vivo
por: Terry, Treniece L., et al.
Publicado: (2021)

Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes
por: Cosco, Donato, et al.
Publicado: (2014)

Method and its Composition for encapsulation, stabilization, and delivery of siRNA in Anionic polymeric nanoplex: An In vitro- In vivo Assessment
por: Raval, Nidhi, et al.
Publicado: (2019)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
por: Ribeiro e Ribeiro, Renan, et al.
Publicado: (2021)

Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug–Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug
por: Lim, Li Ming, et al.
Publicado: (2022)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Delivery of Quantum Dot-siRNA Nanoplexes in SK-N-SH Cells for BACE1 Gene Silencing and Intracellular Imaging
por: Li, Shengliang, et al.
Publicado: (2012)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma
por: Jena, Saubhagya Kumar, et al.
Publicado: (2015)

A data science approach for the classification of low-grade and high-grade ovarian serous carcinomas
por: Lin, Sangdi, et al.
Publicado: (2018)

Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer
por: Akkın, Safiye, et al.
Publicado: (2023)

Diffuse large B‐cell lymphoma versus Burkitt lymphoma with discordant diagnostic cytogenetics: Morphology trumps
por: Shopsowitz, Kevin E., et al.
Publicado: (2021)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Evaluation of mitochondrial biogenesis and ROS generation in high-grade serous ovarian cancer
por: Koc, Zeynep C., et al.
Publicado: (2023)

The Continuum of Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary
por: Wong, Kwong-Kwok, et al.
Publicado: (2007)

Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer
por: Mensah, Lawrence B., et al.
Publicado: (2019)

Oncogenes in high grade serous adenocarcinoma of the ovary
por: Manasa, Pacharla, et al.
Publicado: (2020)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

Characterizing high-grade serous papillary carcinoma of tunica vaginalis
por: Qu, Liang G., et al.
Publicado: (2019)

Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro
por: Correa, Rohann J. M., et al.
Publicado: (2015)

Low Grade Ovarian Serous Carcinoma - A Clinical-Morphologic Study
por: DOCHIȚ, C, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9hovi61sqi697n64351envjsni